Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Hepatitis C Drugs Kill the Virus...and Your Sex Drive
- As the American Association for the Study of Liver Diseases kicks off its annual confab this week, all eyes will be on efforts to revolutionize the standard of care for hepatitis C...especially now that new data show the standard has unfortunate sexual side effects. by Trista Morrison
- Blog posts 2009-10-27
Additional Resources
- Hepatitis C Caring Ambassadors Program Launches Hepatitis C Awareness 2005 Campaign: 100,000 Letters to Congress
- OREGON CITY, Ore. -- The Hepatitis C Caring Ambassadors Program HCCAP enthusiastically announces the launch the Internet-based Hepatitis C Awareness 2005 Campaign (www.hepcchallenge.org), which coincides with the May observance of National Hepatitis Awareness Month. The campaign is focused on raising hepatitis C awareness in the minds of the general public,...
- Research articles 2005-05-05
- Roche's hepatitis C drug price hits competition. (Breaking News: Roundup).(Brief Article)
- Roche has made another aggressive bid for market share in the chronic hepatitis C segment. Just days after announcing the resolution of its patent dispute with ICN Pharmaceuticals Inc. and Ribapharm Inc. over the hepatitis C treatment ribavirin, Ro Roche has made another aggressive...
- Research articles 2003-01-20
- VA Health Care: Further Efforts Needed to Improve Hepatitis C Testing for At-Risk Veterans.
- GAO-04-106 December 12, 2003 Hepatitis C is a chronic disease caused by a blood-borne virus that can lead to potentially fatal liverrelated conditions. In 2001, GAO reported that the VA missed opportunities to test about 50 percent of veterans identified as at risk for hepatitis C. GAO was...
- Research articles 2004-01-01
- VA Health Care: Improvements Needed in Hepatitis C Disease Management Practices.
- GAO-03-136 January 31, 2003 In 1998, the Department of Veterans Affairs VA launched an initiative to screen and test veterans for hepatitis C--a chronic blood-borne virus that can cause potentially fatal liver-related conditions. Since 2001, GAO has been monitoring VA's hepatitis C program. This year GAO was asked...
- Research articles 2003-04-01
- Hepatitis C Caring Ambassadors Program Dismayed by Oregon Governor Ted Kulongoski's Veto of Hepatitis C Legislation
- OREGON CITY, Ore. -- The Hepatitis C Caring Ambassadors Program HCCAP announced that they had received notification on July 19th from the office of Oregon Governor Ted Kulongoski that he had vetoed hepatitis C legislation overwhelmingly passed by both the Oregon House and Senate. The legislation, HB 2480, would have...
- Research articles 2005-07-20
- Bipartisan Hepatitis C Legislation Reintroduced in Both Houses of Congress
- The Hepatitis C Epidemic Control and Prevention Act [SB-1445, HR-2552] has been reintroduced into both Houses of the 110th Congress by Senator Edward Kennedy (D-MA) and Representative Edolphus Towns (D-NY). The Hepatitis C Epidemic Control and Prevention Act mandates a comprehensive federal hepatitis C program to include counseling and...
- Research articles 2007-05-30
- Massive Las Vegas Hepatitis C Scare Causes Public Health Crisis - Edward M. Bernstein & Associates Files Lawsuits
- Over 40,000 Patients during Last Four Years Potentially Exposed to Hepatitis C or HIV Infection in Las Vegas LAS VEGAS -- Edward M. Bernstein & Associates, one of Nevada's leading Personal Injury Law Firms has been retained by former patients of the Endoscopy Center of Southern Nevada, who have...
- Research articles 2008-03-04
- Biota and GlaxoSmithKline finalize hepatitis C agreement. (Markets: Life Sciences).(also mentions Gilead and Ribahparm's hepatitis drugs)(Brief Article)
- GLAXOSMITHKLINE PLC GSK and Biota Holdings Ltd. have finalized a license agreement aimed at developing new drugs for the $2 billion hepatitis C market. For GSK, the deal comes on the heels of a $10 million pact with Gilead Sciences Inc. for hepat GLAXOSMITHKLINE...
- Research articles 2002-08-19
- Could You Have Hepatitis? New Report Shows That the Majority of Europeans With Hepatitis C Remain Undiagnosed.(Disease/Disorder overview)
- BRUSSELS, Belgium, October 1 /PRNewswire/ -- - European Liver Patients Association Urges People at Risk to get Tested! A report(1) released today by the Eurasian Harm Reduction Network EHRNi highlights the significant inconsistencies that exist in hepatitis C HCV diagnosis...
- Research articles 2007-10-01
- Alta Natural Herbs & Supplements Ltd.: B.C. Company Begins Testing Potential Cure for Hepatitis-C
- VANCOUVER, British Columbia--BUSINESS WIRE--July 21, 1998--Alta Natural Herbs (Alberta Stock Exchange:AHS.) (OTC Bulletin Board:AHSNF) A Richmond, B.C. manufacturer of sea based and herbal supplements has announced the launch of human testing of a possible cure for Hepatitis-C.In what may be the best hope yet for over 170 million sufferers of...
- Research articles 1998-07-21
- ViroPharma to Present at the ThinkEquity Partners ThinkTank Forum on Hepatitis C and Genzyme Offer for AnorMed Moves Forward.
- M2 PRESSWIRE-8 November 2006-U.S. Equity News: ViroPharma to Present at the ThinkEquity Partners ThinkTank Forum on Hepatitis C and Genzyme Offer for AnorMed Moves ForwardC1994-2006 M2 COMMUNICATIONS LTD RDATE:08112006 City of Industry, CA - Biotechnology industry alert provided by U.S....
- Research articles 2006-11-08
- US DEPT OF HHS: NIDDK funds clinical centres for he hepatitis C research.
- M2 PRESSWIRE-26 July 1999-US DEPT OF HHS: NIDDK funds clinical centres for hepatitis C research C1994-99 M2 COMMUNICATIONS LTD RDATE:260799 The NIDDK today announced awards of $28 million to fund an 8 year clinical trial of anti-viral drugs on treatment for chronic...
- Research articles 1999-07-26
- Hepatitis C study could lead to development of new drugs, Yale researchers find.
- M2 PRESSWIRE-4 April 2001-YALE UNIVERSITY: Hepatitis C study could lead to development of new drugs, Yale researchers find C1994-2001 M2 COMMUNICATIONS LTD RDATE:04042001 New Haven, Conn. -- Yale researchers have found that the hepatitis C virus HCV uses a...
- Research articles 2001-04-04
- Singer Marianne Faithfull has Hepatitis C
- LONDON AFP — Sixties singer Marianne Faithfull announced Friday she is suffering from Hepatitis C. Faithfull, 60, who was recently treated for breast cancer, said she had been living with the virus since the 1990s. It was while discussing her cancer treatment on ITV 1's 'This Morning' show...
- Research articles 2007-10-12
- Viropharma Inc.. (Markets: Life sciences).(and Wyeth-Ayerst Laboratories discontinue hepatitis C product development)(Brief Article)
- VIROPHARMA Inc. and AHP's Wyeth-Ayerst Laboratories, will stop development for a hepatitis C compound, VP 50406, in ... VIROPHARMA Inc. and AHP's Wyeth-Ayerst Laboratories, will stop development for a hepatitis C compound, VP 50406, in favor of structurally distinct follow-on compounds that the companies...
- Research articles 2001-11-19
- Roche to produce Hepatitis C medicine.(Brief Article)
- Foreign pharmaceutical company Roche said it will produce and send to market a new generation of Pegasys, the Hepatitis C medicine after being licensed by the European Commission on March 21 last year. Pegasys is a new product highly effective in cur Foreign pharmaceutical company Roche...
- Research articles 2002-07-09
- Drug Maker Schering-Plough Seeks to Unbundle Hepatitis C Treatment Package.(Knight Ridder/Tribune Business News)
- Dec. 15--Two years after locking up the burgeoning market for hepatitis C treatment with a controversial 2-in-1 product kit, Schering-Plough Corp. yesterday disclosed it's seeking regulatory approval to sell the two components separately. Dec. 15--Two years after locking up the burgeoning market for ...
- Research articles 2000-12-15
- Valeant Pharmaceuticals to Initiate Clinical Development of Viramidine® in Japan; Valeant Forms Hepatitis C Advisory Board in Japan
- COSTA MESA, Calif. -- Valeant Pharmaceuticals International (NYSE:VRX) today announced plans to initiate the development of ViramidineR in Japan following the first meeting of the company's hepatitis C Japanese advisory board, which was held Monday evening in Tokyo. The company is developing Viramidine, a nucleoside guanosine analog, in oral form...
- Research articles 2005-07-25
- ICN, Schering-Plough and Eli Lilly Forge Ahead With Hepatitis C Drugs.
- ICN PHARMACEUTICALS, Schering-Plough and Eli Lilly & Co. are all making progress in developing drugs to treat hepatitis C. ICN PHARMACEUTICALS, Schering-Plough and Eli Lilly & Co. are all making progress in developing drugs to treat hepatitis C.
- Research articles 1999-05-17
- << Previous
- page 1 of 1
- Next >>
Presented by American Express